June 7, 2026

Breakthrough T1D is attending the American Diabetes Association (ADA) Scientific Sessions in New Orleans, where our team is sharing the latest advances in curing, preventing, and treating type 1 diabetes (T1D) and its complications. We are troubled by Friday’s event, in which several researchers were escorted from the convention center after distributing a published editorial criticizing the Administration’s proposed National Institutes of Health (NIH) budget and policies.

Scientific progress depends on open, respectful dialogue, and that progress has profoundly improved the lives of people living with T1D. Our mission to accelerate life-changing breakthroughs to cure, prevent, and treat T1D and its complications depends on it. Breakthrough T1D will continue to be a strong voice for the funding and policies that make those breakthroughs possible.